236 related articles for article (PubMed ID: 27710140)
21. [Consensus opinion on antifungal prophylaxis in haematologic patients: Results of the PROMIC project].
Vázquez López L; Villaescusa de la Rosa T; de la Cámara R; Espigado I; Grau Cerrato S; Jurado M; Rovira M; Salavert M; Serrano Simonneau D; Solano Vercet C; Ruiz Camps I
Rev Esp Quimioter; 2017 Jun; 30(3):213-223. PubMed ID: 28537063
[TBL] [Abstract][Full Text] [Related]
22. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
Rogers TR; Slavin MA; Donnelly JP
Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
[TBL] [Abstract][Full Text] [Related]
23. Approach to diagnostic evaluation and prevention of invasive fungal disease in patients prior to allogeneic hematopoietic stem cell transplant.
O'Keeffe JC; Singh N; Slavin MA
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14197. PubMed ID: 37988269
[TBL] [Abstract][Full Text] [Related]
24. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Maertens JA; Girmenia C; Brüggemann RJ; Duarte RF; Kibbler CC; Ljungman P; Racil Z; Ribaud P; Slavin MA; Cornely OA; Peter Donnelly J; Cordonnier C; ;
J Antimicrob Chemother; 2018 Dec; 73(12):3221-3230. PubMed ID: 30085172
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of invasive fungal disease in haematologic patients.
Souza L; Nouér SA; Morales H; Simões B; Solza C; Queiroz-Telles F; Nucci M
Mycoses; 2021 Mar; 64(3):252-256. PubMed ID: 33141969
[TBL] [Abstract][Full Text] [Related]
26. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of posaconazole in hematopoietic stem cell transplantation patients with invasive fungal disease.
Zhang S; He Y; Jiang E; Wei J; Yang D; Zhang R; Zhai W; Zhang G; Wang Z; Zhang L; Liu L; Han M; Feng S
Future Microbiol; 2017 Nov; 12():1371-1379. PubMed ID: 28880124
[TBL] [Abstract][Full Text] [Related]
28. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
Michallet M; Ito JI
J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
[TBL] [Abstract][Full Text] [Related]
29. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
[TBL] [Abstract][Full Text] [Related]
30. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
Tacke D; Buchheidt D; Karthaus M; Krause SW; Maschmeyer G; Neumann S; Ostermann H; Penack O; Rieger C; Ruhnke M; Sandherr M; Schweer KE; Ullmann AJ; Cornely OA
Ann Hematol; 2014 Sep; 93(9):1449-56. PubMed ID: 24951122
[TBL] [Abstract][Full Text] [Related]
31. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
[TBL] [Abstract][Full Text] [Related]
32. Clinical practice update of antifungal prophylaxis in immunocompromised children.
Ramos JT; Romero CA; Belda S; Candel FJ; Carazo Gallego B; Fernández-Polo A; Ferreras Antolín L; Garrido Colino C; Navarro ML; Nef O; Olbright P; Rincón-López E; Ruiz Contreras J; Soler-Palacín P;
Rev Esp Quimioter; 2019 Oct; 32(5):410-425. PubMed ID: 31507152
[TBL] [Abstract][Full Text] [Related]
33. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Stemler J; Mellinghoff SC; Khodamoradi Y; Sprute R; Classen AY; Zapke SE; Hoenigl M; Krause R; Schmidt-Hieber M; Heinz WJ; Klein M; Koehler P; Liss B; Koldehoff M; Buhl C; Penack O; Maschmeyer G; Schalk E; Lass-Flörl C; Karthaus M; Ruhnke M; Cornely OA; Teschner D
J Antimicrob Chemother; 2023 Aug; 78(8):1813-1826. PubMed ID: 37311136
[TBL] [Abstract][Full Text] [Related]
34. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.
Fleming S; Yannakou CK; Haeusler GM; Clark J; Grigg A; Heath CH; Bajel A; van Hal SJ; Chen SC; Milliken ST; Morrissey CO; Tam CS; Szer J; Weinkove R; Slavin MA
Intern Med J; 2014 Dec; 44(12b):1283-97. PubMed ID: 25482741
[TBL] [Abstract][Full Text] [Related]
35. Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.
Epstein DJ; Seo SK; Brown JM; Papanicolaou GA
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i60-i72. PubMed ID: 29304213
[TBL] [Abstract][Full Text] [Related]
36. [Prophylaxis of fungal infections in haematological patients: contra].
Schwartz S
Dtsch Med Wochenschr; 2010 Sep; 135(38):1871. PubMed ID: 20842608
[No Abstract] [Full Text] [Related]
37. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
Leather HL; Wingard JR
Blood Rev; 2006 Sep; 20(5):267-87. PubMed ID: 16781028
[TBL] [Abstract][Full Text] [Related]
38. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
39. Prophylaxis for aspergillosis in patients with haematological malignancies: pros and cons.
Busca A; Pagano L
Expert Rev Anti Infect Ther; 2018 Jul; 16(7):531-542. PubMed ID: 30033822
[TBL] [Abstract][Full Text] [Related]
40. Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation.
Itsaradisaikul S; Pakakasama S; Boonsathorn S; Techasaensiri C; Rattanasiri S; Apiwattanakul N
Transplant Proc; 2021; 53(6):2021-2028. PubMed ID: 33994183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
